Clinical Trials Directory

Trials / Unknown

UnknownNCT02064634

A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule

A Multicenter, Comparative, Open Label, Prospective Observational Study on Discontinuation of Medication Due to Gastrointestinal Adverse Effects for the Patients Being Treated for Osteoarthritis With Anti-inflammatory Analgesic Drug

Status
Unknown
Phase
Study type
Observational
Enrollment
6,700 (estimated)
Sponsor
Green Cross Corporation · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study investigates how gastrointestinal toxicity affects discontinuation of medication given to patients with osteoarthritis in routine clinical practice.

Conditions

Timeline

Start date
2014-05-01
Primary completion
2016-06-01
Completion
2016-12-01
First posted
2014-02-17
Last updated
2016-03-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02064634. Inclusion in this directory is not an endorsement.

A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule (NCT02064634) · Clinical Trials Directory